Nephrotic Syndrome I : Introduction
Acute Coronary Syndrome I: Introduction
Irritable Bowel Syndrome I: Introduction
Restless Leg Syndrome and Night Terrors
Acute Coronary Syndrome V: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 24, 2026

A Fluorescence-based Assay of Phospholipid Scramblase Activity
Published on: September 20, 2016
Pierre-Antoine Soret1, Olivier Chazouillères1, Christophe Corpechot1
1Service d'hépatologie, centre de référence des maladies inflammatoires des voies biliaires et des hépatites auto-immunes (MIVB-H), centre de référence européen des maladies rares du foie (Rare-Liver), hôpital Saint-Antoine, AP-HP, Paris, France Sorbonne Université, INSERM, centre de recherche Saint-Antoine (CRSA), Paris, France.
Low phospholipid-associated cholelithiasis (LPAC) syndrome is a rare genetic condition. Diagnosis involves liver ultrasound, and treatment typically includes ursodeoxycholic acid (UDCA).
Area of Science: